Table 4.
External Beam Radiation therapy Only +/−NADT distribution of participant responses to EPIC Hormone/Vitality HRQOL items at baseline, 6, 12, and 24 months.
| NADT | No NADT | P value* | |||||
|---|---|---|---|---|---|---|---|
| How big a problem during the last 4 weeks, if any, has each of the following been for you? | Moderate problem +Big problem | No Problem + Very small problem + Small problem | n | Moderate problem +Big problem | No Problem + Very small problem + Small problem | n | |
| Hot flashes | 0.0924 | ||||||
| Baseline: | 1.2% | 98.8% | 84 | 1.0% | 99.0% | 202 | |
| 6 months: | 33.3% | 66.7% | 78 | 2.2% | 97.8 % | 182 | |
| 12 months: | 20.8% | 79.2% | 77 | 0.5% | 99.5% | 181 | |
| 24 months: | 7.3% | 92.8 % | 69 | 2.4% | 97.6% | 166 | |
| Breast tenderness/enlargement[1] | 0.8611 | ||||||
| Baseline: | 0% | 100% | 85 | 1.5% | 98.5% | 201 | |
| 6 months: | 2.6% | 97.4% | 78 | 1.7% | 98.3% | 181 | |
| 12 months: | 1.3% | 98.7% | 77 | 1.7% | 98.3% | 181 | |
| 24 months: | 2.9% | 97.1% | 69 | 1.2% | 98.8% | 167 | |
| Feeling depressed | 0.8733 | ||||||
| Baseline: | 3.5% | 96.5% | 85 | 6.9% | 93.1% | 202 | |
| 6 months: | 3.9% | 96.2% | 78 | 6.1% | 93.9% | 181 | |
| 12 months: | 6.5% | 93.5% | 77 | 8.3% | 91.7% | 181 | |
| 24 months: | 5.8% | 94.2% | 69 | 4.8% | 95.2% | 167 | |
| Lack of energy | 0.0003 | ||||||
| Baseline: | 5.9% | 94.1% | 85 | 13.9% | 86.1% | 202 | |
| 6 months: | 35.9% | 64.1% | 78 | 14.9% | 85.1% | 181 | |
| 12 months: | 20.8% | 79.2% | 77 | 17.2% | 82.8% | 180 | |
| 24 months: | 15.9% | 84.1% | 69 | 16.8% | 83.2% | 167 | |
| Change in body weight | 0.1251 | ||||||
| Baseline: | 3.6% | 96.4% | 84 | 4.5% | 95.5% | 202 | |
| 6 months: | 12.8% | 87.2% | 78 | 3.9% | 96.1% | 181 | |
| 12 months: | 14.3% | 85.7% | 77 | 3.9% | 96.1% | 179 | |
| 24 months: | 10.1% | 89.9% | 69 | 4.8% | 95.2% | 167 | |
P value reflects a test of the interaction term between group and the time points in linear generalized estimating equations (GEE).
Cochran-Mantel-Haenszel test